Genmab A GNMSF
NASDAQ GNMSF
$335.00 +15.00 (+4.69%)
At close: Aug 20, 2026 · 4:00 PM EDT

Genmab A/S (GNMSF) Current Taxes (2018 - 2026)

Genmab A's (GNMSF) quarterly Current Taxes came in at -$21.0 million in Q1 2026, up 57.14% YoY from -$13.4 million in Q1 2025, and down 148.84% on a QoQ basis from $43.0 million in Q4 2025.

Genmab A/S (GNMSF) Current Taxes (2018 - 2026) Analysis & Trends

Genmab A (GNMSF) has 7 years of Current Taxes data on file, last reported at -$21.0 million in Q1 2026.

  • Quarterly Current Taxes rose 57.14% year-over-year to -$21.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$21.0 million (up 57.14% YoY) and the FY2025 annual result came in at $43.0 million, down 82.01% from the prior year.
  • Current Taxes declined to -$21.0 million in Q1 2026, from $43.0 million in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $239.0 million in Q4 2024 to a low of -$228.0 million in Q3 2024.
  • A 4-year average of -$57.9 million and a median of -$53.0 million in 2024 frame the typical range for Current Taxes.
  • Annual changes were most pronounced in 2024 — Current Taxes surged 2887.5% — and 2025, when it sank 82.01%.
  • Tracing GNMSF's Current Taxes over 4 years: stood at $8.0 million in 2023, then surged by 2887.5% to $239.0 million in 2024, then slumped by 82.01% to $43.0 million in 2025, then slumped by 148.84% to -$21.0 million in 2026.
  • The last three Current Taxes figures came in at -$21.0 million (Q1 2026), $43.0 million (Q4 2025), and -$217.0 million (Q3 2025), per Business Quant data.

Peer Comparison

Historic Data

Download Data
DateValue
Mar 31, 2026 -21.00 Mn
Dec 31, 2025 43.00 Mn
Sep 30, 2025 -217.00 Mn
Jun 30, 2025 -136.00 Mn
Mar 31, 2025 -49.00 Mn
Dec 31, 2024 239.00 Mn
Sep 30, 2024 -228.00 Mn
Jun 30, 2024 -161.00 Mn
Mar 31, 2024 -57.00 Mn
Dec 31, 2023 8.00 Mn
Sep 30, 2020 1,226.00
Dec 31, 2019 -162.00
Sep 30, 2019 59.32 Mn
Dec 31, 2018 -51.42 Mn